-+ 0.00%
-+ 0.00%
-+ 0.00%

LifeSci Capital Initiates Coverage On Sionna Therapeutics with Outperform Rating, Announces Price Target of $60

Benzinga·12/23/2025 16:09:16
Listen to the news
LifeSci Capital analyst Cory Jubinville initiates coverage on Sionna Therapeutics (NASDAQ:SION) with a Outperform rating and announces Price Target of $60.